Innoviva, Inc.
INVA
$20.86
$0.281.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.61% | 0.68% | 61.52% | 48.85% | 136.86% |
| Total Other Revenue | 4.98% | 0.22% | -1.04% | -5.51% | 6.53% |
| Total Revenue | 20.44% | 0.39% | 14.37% | 6.95% | 33.08% |
| Cost of Revenue | 155.61% | 68.36% | 62.30% | -50.45% | -2.25% |
| Gross Profit | 3.27% | -8.05% | 8.84% | 52.56% | 39.48% |
| SG&A Expenses | 4.39% | -4.79% | -9.58% | 19.02% | -8.30% |
| Depreciation & Amortization | 1.64% | 1.66% | 0.54% | 0.02% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.25% | 13.98% | 4.70% | 16.41% | -6.18% |
| Operating Income | -20.03% | -10.85% | 27.64% | -1.43% | 141.00% |
| Income Before Tax | 1,328.19% | 284.83% | -185.52% | -59.65% | -92.03% |
| Income Tax Expenses | 40.33% | 293.95% | -6.95% | 1,421.82% | 44.29% |
| Earnings from Continuing Operations | 7,312.04% | 283.62% | -227.52% | -66.96% | -98.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7,312.04% | 283.62% | -227.52% | -66.96% | -98.52% |
| EBIT | -20.03% | -10.85% | 27.64% | -1.43% | 141.00% |
| EBITDA | -17.17% | -9.51% | 23.09% | -1.25% | 103.33% |
| EPS Basic | 6,610.82% | 282.64% | -228.48% | -66.38% | -98.46% |
| Normalized Basic EPS | -23.33% | -6.62% | 36.20% | 7.19% | 162.64% |
| EPS Diluted | 5,474.74% | 239.30% | -260.80% | -63.01% | -98.03% |
| Normalized Diluted EPS | -37.28% | -30.49% | 82.26% | 6.35% | 246.14% |
| Average Basic Shares Outstanding | 10.37% | 0.54% | -0.75% | -1.70% | -3.67% |
| Average Diluted Shares Outstanding | 34.97% | 35.07% | -25.82% | -0.94% | -26.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |